EU regulator backs Eisai-Biogen Alzheimer’s drug
EU drugs regulator recommends approval of Leqembi for early Alzheimer's, pending European Commission acceptance, for specific patient group.
The European Union’s drugs regulator on Thursday (November 14, 2024) recommended approval of Eisai and Biogen’s Leqembi for some patients with early Alzheim...
Read More
Other Stories in Health
- Weekly Horoscope For January 20-26, 2025, From The AstroTwins
- Reiterating the cancer risks of alcohol consumption
- Heart Health: 7 small changes in our habits that protect our heart diseases
- Monkey Spit, LLC Issues Allergy Alert on Undeclared Milk/Wheat/Soy in Monkey Spit BBQ Sauces
- Best of Comments from the Haters!
- Think Salads Are Boring? This Creamy, Crunchy Potato Chip Salad Will Change Your Mind
- What makes a drug “special”? – Healthcare Economist
- ND Alert on HB 1131: Support Raw Dairy Product Sales in North Dakota (House cmte)
- Eye Fatigue: Everyday habits that will keep your eyes fresh and sharp
.png)
